Study of vortioxetine for teens with depression in Japan
Treatments studied
Part of Mental health clinical trials.
This trial tests whether vortioxetine helps reduce symptoms of major depression in Japanese teenagers aged 12-17. It compares the study drug to a placebo to see if it is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 12 and 17 years old and live in Japan.
- You have been diagnosed with major depressive disorder or persistent depressive disorder with a current major depressive episode.
- Your depression symptoms are at least moderate in severity.
- You have not tried vortioxetine before.
- You are not currently taking other antidepressants that would interfere.
- You and your parent or guardian can attend all study visits and agree to video recordings for assessment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether bupropion helps children and teens with major depressive disorder (MDD) and checks its safety. You may be able to join if your depression symptoms fit specific scoring and timing rules.
This trial uses computer modeling based on brain measurements to try to predict which depression treatment will work for you. It may help match you with the most effective option faster by understanding your motivation-related brain patterns.
This study tests a long-term treatment for adults with recurrent depression who haven't already tried many other antidepressants. It checks whether the medication is safe and helpful over time.
This study tests a new oral medication, KH607, against an existing antidepressant (vortioxetine) to see which is more effective and safer for adults with moderate-to-severe depression. Participants will receive one of the two treatments for several weeks, with the option to continue in a longer-term phase if they respond well.
This trial tests a step-by-step approach to treating moderate-to-severe depression in teens. It may help find a treatment path that improves mood while keeping care safe, including for some teens who have suicidal thoughts but do not need inpatient care.
This study tests whether vortioxetine, a depression medication, can help people who have both depression and episodic migraine (recurring headaches). You'd take vortioxetine for depression while researchers track how it affects both your mood and migraine symptoms.
Hear when a new Major Depressive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.